Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - A randomised controlled pragmatic non-inferiority strategy trial
Annals of Rheumatic Diseases Sep 20, 2017
Bouman CAM, et al. - The long-term outcomes of TNFi DR in RA by utilizing 3-year data from the DRESS study (Dose REduction Strategy of Subcutaneous TNF inhibitors study) are evaluated in this study. Safety and effectiveness of disease activity guided TNFi DR in RA are maintained up to 3 years, with a large reduction in TNFi utilization, but no other benefits. Implementation of DR would vastly improve the cost-effective utilization of TNFi.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
